iCureCeliac® speeds study enrollment by providing instant access to a diverse sample of more than 15,000 patients who meet your criteria – saving you time and money. Launched in 2016 as a research network funded by the Patient-Centered Outcomes Research Institute (PCORI), iCureCeliac® is the largest public celiac disease database driving novel research with dynamic health data and patient insights.
Access our expansive database of demographic, biomarker, and healthcare data to pinpoint iCureCeliac® registry participants who match your subject profile and invite them to participate, quickly delivering highly-qualified and motivated participants to your study.
iCureCeliac® captures longitudinal health data across the entire diagnostic and treatment journey for people with celiac disease. Patients are empowered to contribute insights on the topics they care about most, ensuring that the future of celiac disease research reflects the diversity of real-world data. Validated instruments include the Celiac Symptoms Index (CSI), Celiac Dietary Adherence Test (CDAT), Celiac Disease Quality of Life Measure (CD-QOL), SF-36, PROMIS Gastrointestinal, PROMIS 29 Profile and PROMIS Pediatric 25 Profile.